A new study launching at Sutter’s California Pacific Medical Center (CPMC) will use antibody tests to identify front-line doctors who have developed antibodies against the virus. Antibody tests (also called “serology tests” because they use blood samples) are used to determine if someone is producing antibodies to defend against the virus. “A powerful way to …
Sutter participates in international HIV prevention study of cabotegravir, bringing new science to advance care at East Bay AIDS Center.
Testing is conducted to diagnose, understand and help prevent the spread of SARS-CoV-2/novel coronavirus. Follow our Educational Series on testing to stay abreast of the latest updates at Sutter. In Part 2 of this series, we describe antibody tests for SARS-CoV-2.
Shining Light on Mental Health: Research at Sutter Helps Reimagine the Future of Mental Health for At-risk Youth
As the novel coronavirus pandemic ushers in uncertainty that may evoke anxiety, depression or other mental health concerns for today’s youth, what would a new vision for their mental health look like? New screening tools for early detection of severe depression and suicide risk, as well as a novel program called Youth Mental Health Reimagined may be part of the path forward.
Differences in How People Access Care Contribute to Inequalities SACRAMENTO, CALIF. – As the COVID-19 pandemic spreads throughout the U.S., evidence is mounting that racial and ethnic minorities and socioeconomically disadvantaged groups are bearing a disproportionate burden of illness and death. Here in California, African Americans are about 6% of the California population, but make …
Follow our Educational Series on testing to learn about polymerase chain reaction (PCR) and serology testing, and stay abreast of the latest updates at Sutter. In Part 1 of this series, we describe SARS-CoV-2 testing with PCR.
When a global health crisis began endangering communities across Northern California, Sutter research and operational staff started brainstorming new ways to track the spread of COVID-19 and launch strategies for early detection and ongoing surveillance. Learn how these data detectives are partnering to bring top-quality care to patients and communities across Sutter’s integrated network.
rapy to medication for treating insomnia in rural adults. Results may be especially important as physicians seek alternative ways of providing sleep therapy during the SARS-CoV-2 pandemic.
Every day brings new scientific insights into COVID-19, read about two new studies from Sutter Health experts.
Paying it Forward: Sutter Teams with Vitalant to Offer COVID-19 Survivor-Donated Blood Plasma to Patients
New research suggests blood plasma collected from people who have recovered from COVID-19 may help treat patients with severe cases of the disease. Learn how Sutter’s new partnership with Vitalant will deliver this ground-breaking care to patients.